Shaily Engineering Q1 FY27: revenue up 14%, EBITDA up 18%, Healthcare now 51% of mix

Mgmt Guided Margin ImprovementOrder Pipeline DisclosedMgmt Evaded Key QuestionInvestor Communications View source PDF Explain this filing

SHAILY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.0%1-day move

₹3381.20

prior close

₹3395.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.0+0.5+0.1-0.3-0.0-0.9-1.7———————

Up moveDown movePending

AI summary

Shaily Engineering Q1 FY27: revenue up 14% YoY to INR281 cr, EBITDA up 18% to INR83 cr (margin 29.7%, up 120 bps), PAT up 17% to INR48 cr. Healthcare surged 85% to INR142 cr (51% of mix), Consumer fell 24% to INR116 cr, Industrial grew 25% to INR23 cr. Pen injector capacity to reach 75 million by end September. Mgmt expects to beat 36 million pen guidance. Abu Dhabi plant 50-55% committed, commercial sales by end FY28. New Consumer Electronics and Semiconductor Tray investments underway.

Likely market impact

Strong quarter with Healthcare-led growth and margin expansion; upbeat tone on beating pen guidance, though Consumer segment remains weak.